-
Antibiotic prescribing by GPs in England fell by 17% during the first 12 months of Covid without the usual winter increase
New research by Antibiotic Research UK hints at scale of over-prescribing in normal times. Antibiotic Research UK commissioned an analysis of new antibiotic prescription data ahead of World Antimicrobial Awareness Week (WAAW), 18–24 November, and European Antibiotic Awareness Day (EAAD), 18 November. Key findings include: York, UK, 11th November 2021 / Sciad Newswire / Antibiotic Research UK…
-
Chemineau develops new nasal spray production line with Flexicon filling system
Watson-Marlow’s Flexicon filling system has been chosen for use by the French drug development and manufacturing laboratory, Chemineau The system will be used to aid the development of a new production line of nasal sprays Flexicon PD12P was chosen for its dispensing accuracy, reliability, and ease of integration Falmouth, UK, 10th November 2021 / Sciad Newswire / Chemineau, a…
-
Birmingham Biotech and the University of Birmingham sign licensing agreement for anti-viral nasal spray against COVID-19
Birmingham, UK, 9th November 2021 / Sciad Newswire / Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, and the University of Birmingham have signed a licensing agreement to commercialise a novel anti-viral nasal spray that protects against COVID-19. COVID-19 is both contracted and transmitted by inhalation of droplets or aerosols containing the…
-
Exclusive interview with Professor Sir John Bell announced as Life Science Integrates celebrates ten years of Pharma Integrates
London, UK, 3rd November 2021 / Sciad Newswire / Life Science Integrates (LSI) is delighted to announce the exciting agenda for their flagship event, Pharma Integrates, held live online on 16th November 2021. In its 10th year running, Pharma Integrates 2021 promises to be the biggest yet, with 17+ panel discussions, a record number of speakers, and opening sessions from high-profile…
-
Antibiotic Research UK awards grants to fund research worth £200,000
York, UK, 2nd November 2021 / Sciad Newswire / Antibiotic Research UK (ANTRUK), the world’s first charity tackling bacterial antibiotic resistance, is delighted to announce that it is funding seven new antibiotic research projects totalling £200,000, the largest sum it has ever awarded through its 2021 Small Research Grants / Career Development Awards scheme. The grants will fund essential academic…
-
Antibiotic Research UK’s annual lecture calls for global governments to transform funding of new antibiotic sales to prevent another health emergency
London, UK, 28th October 2021 / Sciad Newswire / The UK’s first charity focused on antibiotic resistance, Antibiotic Research UK (ANTRUK), hosted its annual lecture in London on Thursday 21st October to bring together experts in research, health economics and politics. The annual lecture was delivered by Professor Kevin Outterson, Executive Director of Combating Antibiotic-Resistant Bacteria Biopharmaceutical…
-
Pandemic innovations offer potential to drive advances in personalized medicine
New article discusses how COVID-19 biopharmaceutical innovations could drive advances in personalized medicine Watson-Marlow Fluid Technology Group shares insights from the Personalized Medicine Coalition Falmouth, UK and Washington D.C., USA, 19th October 2021 / Sciad Newswire / Watson-Marlow Fluid Technology Group (WMFTG), a global leader in fluid management technology, releases a new article discussing the potential for exciting advances in the field…
-
Rousselot® Biomedical launches Quali-Pure™, a range of gelatins with controlled purity, supporting full compliance with new EU Medical Device Regulations and ISO 22442
Irving, USA, 19th October 2021 / Sciad Newswire / Rousselot®, the Health brand of Darling Ingredients and the global leader of collagen-based solutions launches Quali-Pure™, a range of gelatins for biomedical applications with controlled endotoxin levels. The latest addition to Rousselot Biomedical’s rapidly expanding portfolio, Quali-Pure, has been specifically designed for a variety of applications including embolization, wound…
-
Announcing the inaugural Advanced Therapies Integrates event – enabling strategic debate and collaboration across the Advanced Therapies and Medicinal Products (ATMP) Industry
London, UK, 1st October 2021 / Sciad Newswire / Life Science Integrates (LSI) is delighted to announce the inaugural Advanced Therapies Integrates event on 7th October 2021, hosted live online in partnership with The Cell and Gene Therapy Catapult. The past years have seen an intense global focus on healthcare like never before. Life Science Integrates aims to facilitate the translation…
-
Exciting new five-year strategy unveiled by Antibiotic Research UK
York, UK, 29th September 2021 / Sciad Newswire / Antibiotic Research UK (ANTRUK) announces the launch of its new five-year strategy, aiming to create a world free from deaths caused by drug-resistant infections. The strategy focuses on driving innovative research into new treatments, supporting patients and families, and raising awareness to reduce the spread of drug-resistant infections. This…